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laque Rupture and Intracoronary
hrombus in Nonculprit Vessels
n Eyewitness Account*
ohn A. Ambrose, MD, FACC,†
avid J. D’Agate, DO†
ew York, New York
ver the last 25 years, there has been enormous progress in
nderstanding the pathogenesis of acute coronary syn-
romes (ACS) and the pathobiology of atherosclerosis and
therothrombosis. Nonocclusive, mural, or occlusive intra-
oronary thrombus (ICT) has been established as the cause
f nearly all acute myocardial infarctions (AMIs), a majority
f non–ST-segment elevation ACS, and a large proportion
f patients with sudden cardiac death (SCD) (1,2). The
therosclerotic process underlying ICT is usually either
laque disruption (PD) or erosion (3). Plaque inflammation
fuels the fires” of atherosclerosis contributing to plaque
isruption and erosion, as well as to the initiation and
rogression of the atherosclerotic process (4).
See page 652
In addition to its important role in ACS, incorporation of
hrombus into the vessel wall has been found to be a
echanism for the asymptomatic progression of atheroscle-
osis (5). The thrombus organizes and becomes covered by
eointima, increasing plaque burden and contributing to a
eduction in lumen diameter. Along with plaque hemor-
hage, presumably from rupture or leakage of vasa vasorum
hat has neovascularized the plaque (6), these two processes
ontribute significantly to the non-linear progression of
therosclerosis.
Recent information has also indicated that PD and/or
CT may be multifocal and not limited to the culprit lesion
n patients presenting with an ACS. Multiple studies
tilizing different imaging modalities for analysis have
onfirmed or expanded upon previous pathologic studies of
he coronary arteries from patients dying of AMI or SCD,
howing that multiple sites of “vulnerable plaque” or PD
ay be present in a significant percentage of patients
7–11). Most of these other sites are clinically silent, and
ultiple PDs may be accompanied by a heightened systemic
nflammatory response (12,13).
Despite the recent progress made in elucidating the role
f ICT in ACS and the progression of atherosclerosis, the
*Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.v
From the †Saint Vincent Catholic Medical Centers of New York, New York
edical College, New York, New York.maging modalities in humans have significant limitations in
efining ICT. Although coronary angiography is used
xtensively for this purpose, it is not a sensitive modality for
hrombus detection or in following the asymptomatic pro-
ression of atherosclerosis. Intravascular ultrasound can
uantitatively analyze changes in atherosclerotic progression
ut cannot adequately differentiate soft plaque from throm-
us (14). Although it is not widely available, angioscopy is
urrently the only in vivo technique to accurately assess the
resence of ICT in coronary artery disease, since it directly
isualizes the luminal surface of the vessel wall. Although
reatly limited by patient selection and technical challenges
i.e., balloon occlusion of the coronary artery before visual-
zation), angioscopy has provided insight into the patho-
hysiology of ACSs, the natural history of thrombus after
yocardial infarction, and the mechanism of acute closure
fter balloon angioplasty (15–17).
In this issue of the Journal, Takano et al. (18) utilized
ngioscopy to evaluate by direct visualization 48 thrombi in
0 ruptured coronary plaques from non-culprit lesions in 30
atients. Percent diameter stenosis of the target plaques by
uantitative coronary angiography analysis and the serum
-reactive protein (CRP) level were measured (18). The
ean angioscopic follow-up period was 13  9 months.
uperimposed thrombi still remained at follow-up in 35
esions, and the predominant thrombus color changed from
ed (56%) at baseline to pinkish-white (83%) at follow-up.
he healing rate of ICT increased according to the angio-
copic follow-up period (12 months, 23% vs. 12
onths, 55%; p  0.044). The percent diameter stenosis at
he healed plaque increased from baseline to follow-up (12.3
5.8% vs. 22.7  11.6%), whereas in non-healed plaque,
here was no angiographic progression. The serum CRP
evel in patients with healed plaques (n  10) was lower
han in those without healed plaques (n 19), (0.07 0.03
g/dl vs. 0.15  0.11 mg/dl, respectively; p  0.007), and
tatin use was significantly more common in patients with
ealed plaque. The authors concluded that ruptured plaques
n nonculprit lesions tended to heal slowly with a progres-
ion of angiographic stenosis, and the serum CRP level
ight reflect the disease activity of ruptured plaques.
The findings of Takano et al. (18) provide several
nteresting observations. Intracoronary thrombus was
resent in nonstenotic lesions and associated in 90% of
ases with underlying plaque rupture. Intracoronary throm-
us persisted over time, and healed thrombus contributed to
he asymptomatic progression of angiographic stenosis.
igher CRP and no statin use predicted the non-healing
persistence of thrombus) in univariate analysis, although
ot in their multivariate analysis. Previous work has sug-
ested that elevated CRP may predict progression of ath-
rosclerosis in this population (19). That ICT would persist
ver time suggests that there is a persistent inflammatory or
hrombotic stimulus. Although it was possible that the ICT
isualized represented recurrent thrombus and not persis-
t
t
s
i
(
r
A
a
t
o
n
a
s
t
r
p
o
h
a
t
t
s
i
n
l
s
m
T
m
b
u
g
t
o
t
b
o
(
v
a
a
l
a
a
c
R
1
j
R
1
1
1
1
1
1
1
1
1
1
2
2
660 Ambrose and D’Agate JACC Vol. 45, No. 5, 2005
Editorial Comment March 1, 2005:659–60ent thrombus, the exact mechanism for this persistent
hrombus remains elusive. Given the known interrelation-
hip between inflammation and thrombosis, a heightened
nflammatory state could promote a prothrombotic milieu
20).
Another interesting and unexplained observation was
elated to thrombus color as detected by angioscopy. In an
CS without total occlusion, the thrombus is usually white
nd presumed platelet-rich. Only with total occlusion was
he thrombus red, with red cells and fibrin overlying a nidus
f platelets (15). In the Takano et al. study (18), the
onocclusive thrombus in nonobstructed arteries was red in
majority of cases. On the other hand, a white thrombus as
een in unstable angina requires significant luminal obstruc-
ion at the site of PD and altered flow patterns (high shear
ates) in addition to a prothrombotic milieu (21). Although
inkish-white thrombus was detected by Takano et al. (18)
n follow-up, we suspect that this represents a partially
ealed thrombus, with the white color related to collagen
dmixed with thrombotic components.
Lastly, as discussed in this paper, what determines if the
hrombus is asymptomatic or leads to clinical manifesta-
ions? As pointed out by Takano et al. (18), the presence of
ymptoms is multifactorial and dependent on several factors,
ncluding atherosclerotic plaque burden, percent diameter
arrowing, and the prothrombotic milieu.
This article, although thought-provoking, has several
imitations. 1) The patient population was small and highly
elected. 2) It remains unknown what method was used to
easure CRP and what the upper limits of normal were. 3)
here was also no measurement of additional thrombotic
arkers such as fibrinogen, and the duration of antithrom-
otic therapy in patients with or without healing ICT was
nknown. 4) Whether there was progression of angio-
raphic diameter stenosis at follow-up in lesions without
hrombosis (a control group) was not reported. 5) The
riginal percutaneous coronary intervention may have con-
ributed to nonhealing of ICT (injury from the wire or
alloon) if the nonculprit ICT was in the same vessel as the
riginal intervention.
Despite the above limitations, the paper by Takano et al.
18) contributes to our understanding of ICT as observed in
ivo, including its role in the asymptomatic progression of
therosclerosis. In the future, improvements in non-invasive
nd invasive imaging may expand on these observations in a
arger and less selected population. These data also suggest
potential role for appropriate long-term antithrombotic/
nticoagulant therapy, not only in reducing future acute
oronary events but also as anti-atherosclerotic therapy.
eprint requests and correspondence: Dr. John A. Ambrose,
70 West 12th Street, New York, New York 10011. E-mail:
amambrose@yahoo.com.EFERENCES
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